XBiotech Inc. (FRA:4XB)

Market Cap	59.68M
Revenue (ttm)	n/a
Net Income (ttm)	-24.85M
Shares Out	n/a
EPS (ttm)	-0.82
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	280
Open	1.810
Previous Close	1.820
Day's Range	1.810 - 1.810
52-Week Range	1.690 - 7.050
Beta	n/a
RSI	43.34
Earnings Date	Nov 17, 2025

About XBiotech

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 an...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2005
• Employees: 92
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4XB

Financial Performance

Financial numbers in USD